StockNews.com lowered shares of Eagle Pharmaceuticals ( NASDAQ:EGRX – Get Rating ) from a buy rating to a hold rating in a research report report published on Friday. Separately, Piper Sandler decreased their price objective on shares of Eagle Pharmaceuticals from $31.00 to $26.00 in a report on Wednesday, May 10th. Shares of EGRX stock opened at $20.45 on Friday. The company's fifty day moving average price is $26.51 and its two-hundred day moving average price is $29.67. The firm has a market capitalization of $267.

https://www.dailypolitical.com/2023/05/29/eagle-pharmaceuticals-nasdaqegrx-stock-rating-lowered-by-stocknews-com.html

#dailypolitical